NCT04344509|Unknown
Loading search results
Sponsor study identifier
observational
10,000
0 countries
N/A
Study Start
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
September 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
National multicentric observational retrospective case-control study comparing the relative frequency of the various microorganisms responsible for VAP in patients infected or not by SARS-CoV-2 and their resistance to antibiotics.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 10, 2020
Actual (reported)April 14, 2020
Actual (reported)June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Prevalence of the microorganisms responsible for VAP among patients infected or not by the SARS-CoV-2
1 month
Prevalence of multi-drug resistant bacteria responsible for VAP among patients infected or not by the SARS-CoV-2
1 month
in the respiratory specimen
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.
First Submitted
April 10, 2020
First Posted
April 14, 2020
Study Start
June 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
September 2020
Estimated (date passed)Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 2, 2020
Record last verified: 2020-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: